Skip to main content
. 2024 Feb 8;25(4):343–350. doi: 10.3348/kjr.2023.0907

Table 3. PPVs for the four score groups according to clinical and radiological factors.

Variable Group 1 (10–49) Group 2 (50–69) Group 3 (70–89) Group 4 (90–99) Overall P *
Overall 9.3 (38/409) 33.8 (25/74) 66.0 (33/50) 95.1 (117/123) 32.5 (213/656) < 0.001
Indication
Screening 5.1 (12/235) 29.0 (9/31) 57.9 (11/19) 96.3 (26/27) 18.6 (58/312) < 0.001
Diagnostic 14.9 (26/174) 37.2 (16/43) 71.0 (22/31) 94.8 (91/96) 45.1 (155/344) < 0.001
P 0.001 0.457 0.349 0.725 < 0.001
Palpability
Yes 16.0 (20/125) 47.1 (16/34) 69.7 (23/33) 94.7 (90/95) 51.9 (149/287) < 0.001
No 6.3 (18/284) 22.5 (9/40) 58.8 (10/17) 96.4 (27/28) 17.3 (64/369) < 0.001
P 0.007 0.023 0.449 0.686 < 0.001
Density
Category A 16.7 (1/6) 75.0 (3/4) 100.0 (2/2) 100.0 (4/4) 62.5 (10/16) 0.038
Category B 20.0 (7/35) 66.7 (4/6) 77.8 (7/9) 100.0 (32/32) 61.0 (50/82) < 0.001
Category C 7.3 (16/218) 27.5 (11/40) 58.6 (17/29) 90.0 (54/60) 28.2 (98/347) < 0.001
Category D 9.3 (14/150) 29.2 (7/24) 70.0 (7/10) 100.0 (27/27) 26.1 (55/211) < 0.001
P 0.105 0.076 0.501 0.085 < 0.001
Finding
Asymmetry 13.9 (11/79) 31.6 (6/19) 28.6 (2/7) 80.0 (8/10) 23.5 (27/115) < 0.001
Distortion 40.0 (2/5) 75.0 (3/4) 100.0 (2/2) 100.0 (2/2) 69.2 (9/13) 0.279
Mass 22.4 (11/49) 64.7 (11/17) 77.8 (21/27) 96.2 (50/52) 64.1 (93/145) < 0.001
Mass with microcalcifications 35.7 (5/14) 40.0 (2/5) 75.0 (3/4) 97.7 (42/43) 78.8 (52/66) < 0.001
Microcalcifications only 8.1 (9/111) 13.6 (3/22) 50.0 (5/10) 93.8 (15/16) 20.1 (32/159) < 0.001
Negative 0.0 (0/151) 0.0 (0/7) NA (0/0) NA (0/0) 0.0 (0/158) NA
P 0.008 0.009 0.079 0.213 < 0.001

Data are presented as a percentage of the number of breasts.

*P-value calculated for the difference in PPV among score groups, P-value calculated for difference in PPV between/among column categories in each variable (e.g., screening vs. diagnostic).

PPV = positive predictive value, NA = not applicable